Skip to main content
Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes, genes.
Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in cancer.
As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

More about this publication?
Volume 7, Number 3, 2007

Articles

Glycogen Synthase Kinase-3 Beta; A New Target in Pancreatic Cancer?
pp. 209-215(7)
Authors: Garcea, G.; Manson, M. M.; Neal, C. P.; Pattenden, C. J.; Sutton, C. D.; Dennison, A. R.; Berry, D. P.

Favourites:
ADD

Metastasis-Associated Protein S100A4: Spotlight on its Role in Cell Migration
pp. 217-228(12)
Authors: Tarabykina, S.; L. Griffiths, T. R.; Tulchinsky, E.; Mellon, J. K.; Bronstein, I. B.; Kriajevska, M.

Favourites:
ADD
Favourites:
ADD

Non-Homologous DNA End Joining in Anticancer Therapy
pp. 243-250(8)
Authors: Pastwa, Elzbieta; Malinowski, Mariusz

Favourites:
ADD

The Kinase Inhibitor Imatinib - An Immunosuppressive Drug?
pp. 251-258(8)
Authors: Wolf, D.; Tilg, H.; Rumpold, H.; Gastl, G.; Wolf, A. M.

Favourites:
ADD

MUC1 is a Promising Therapeutic Target for Prostate Cancer Therapy
pp. 259-271(13)
Authors: Li, Y.; Cozzi, P. J.

Favourites:
ADD

Current Status and Future of Target-Based Therapeutics
pp. 273-284(12)
Authors: Suzuki, Ryoko; Rao, Parijatha; Sasaguri, Shiro

Favourites:
ADD

Conditionally Replicating Adenoviruses for Cancer Treatment
pp. 285-301(17)
Authors: Jounaidi, Youssef; Doloff, Joshua C.; Waxman, David J.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content